120 related articles for article (PubMed ID: 17710794)
1. Chronic myeloid leukemia evolving after idiopathic myelofibrosis.
Bennett M; Chubar E
Isr Med Assoc J; 2007 Jul; 9(7):562-3. PubMed ID: 17710794
[No Abstract] [Full Text] [Related]
2. [New breakpoints of t(9;22) translocation in chronic myeloid leukemia].
Misiurin AV; Surin VL; Tagiev AF
Bioorg Khim; 1999 Mar; 25(3):234-6. PubMed ID: 10382043
[No Abstract] [Full Text] [Related]
3. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
[No Abstract] [Full Text] [Related]
4. Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis.
Jallades L; Hayette S; Tigaud I; Johnston A; Coiffier B; Magaud JP; Ffrench M
Leuk Res; 2008 Oct; 32(10):1608-10. PubMed ID: 18448166
[TBL] [Abstract][Full Text] [Related]
5. The first report of chronic myelogenous leukemia with e19a2 micro-BCR/ABL1 presenting with massive myelofibrosis.
Kim HY; Park S; Kim SH; Kim HJ
Blood Cells Mol Dis; 2017 Jun; 65():68-70. PubMed ID: 28571780
[No Abstract] [Full Text] [Related]
6. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML.
Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM
Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799
[No Abstract] [Full Text] [Related]
7. A masked BCR/ABL rearrangement in a case of chronic myeloid leukemia with translocation t(3;9)(p14;q34).
Bennour A; Sennana H; Laatiri MA; Khelif A; Saad A
Cancer Genet Cytogenet; 2008 Feb; 181(1):72-4. PubMed ID: 18262060
[No Abstract] [Full Text] [Related]
8. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
[TBL] [Abstract][Full Text] [Related]
9. CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene.
Diamond JM; de Almeida AM; Belo HJ; da Costa MP; Cabeçadas JM; Abecasis MM
Ann Hematol; 2016 Dec; 95(12):2101-2104. PubMed ID: 27699446
[No Abstract] [Full Text] [Related]
10. Chronic myeloid leukemia with a novel four-way t(6;13;9;22)(p21;q32;q34;q11.2) successfully treated with imatinib mesylate.
Kubota Y; Waki M
Cancer Genet Cytogenet; 2010 Sep; 201(2):135-6. PubMed ID: 20682400
[No Abstract] [Full Text] [Related]
11. Concomitant appearance of trisomy 8 and isochromosome 17q in a Philadelphia-positive clone in a patient with chronic myeloid leukemia in chronic phase: an alarm for changing therapeutic strategy.
Orciuolo E; Buda G; Galimberti S; Sordi E; Cervetti G; Petrini M
Cancer Genet Cytogenet; 2007 Sep; 177(2):166-7. PubMed ID: 17854678
[No Abstract] [Full Text] [Related]
12. Conventional cytogenetics and FISH in the detection of BCR/ABL fusion in chronic myeloid leukemia (CML).
Mark HF; Sokolic RA; Mark Y
Exp Mol Pathol; 2006 Aug; 81(1):1-7. PubMed ID: 16729999
[No Abstract] [Full Text] [Related]
13. Location of the BCR-ABL fusion gene on the 9q34 band in two cases of Ph-positive chronic myeloid leukemia.
Aurich J; Dastugue N; Duchayne E; Schlaifer D; Rigal-Huguet F; Caballin MR
Genes Chromosomes Cancer; 1997 Oct; 20(2):148-54. PubMed ID: 9331565
[TBL] [Abstract][Full Text] [Related]
14. Fatigue and abdominal fullness in a 36-year-old woman.
Archer TP; Kourlas PJ; Mazzaferri EL
Hosp Pract (1995); 1998 Mar; 33(3):141-2, 145-6. PubMed ID: 9522839
[No Abstract] [Full Text] [Related]
15. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
Matolcsy A
Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
[TBL] [Abstract][Full Text] [Related]
16. Chronic myeloid leukemia with p210 BCR-ABL and monocytosis.
Dass J; Jain S; Tyagi S; Sazawal S
Leuk Lymphoma; 2011 Jul; 52(7):1380-1. PubMed ID: 21425959
[No Abstract] [Full Text] [Related]
17. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia.
Haigh S; Cuthbert G
Cancer Genet Cytogenet; 2004 Dec; 155(2):132-7. PubMed ID: 15571798
[TBL] [Abstract][Full Text] [Related]
19. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).
Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G
Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.
Kandarpa M; Wu YM; Robinson D; Burke PW; Chinnaiyan AM; Talpaz M
Am J Hematol; 2017 Jun; 92(6):555-561. PubMed ID: 28335073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
